RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Carisma Therapeutics Stock

Carisma Therapeutics ROCE 2024

Carisma Therapeutics ROCE

-3.34

Ticker

CARM

ISIN

US14216R1014

WKN

A3DZG2

In 2024, Carisma Therapeutics's return on capital employed (ROCE) was -3.34, a -3,984.5% increase from the 0.09 ROCE in the previous year.

Carisma Therapeutics Aktienanalyse

What does Carisma Therapeutics do?

Carisma Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Carisma Therapeutics's Return on Capital Employed (ROCE)

Carisma Therapeutics's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Carisma Therapeutics's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Carisma Therapeutics's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Carisma Therapeutics’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Carisma Therapeutics stock

What is the ROCE (Return on Capital Employed) of Carisma Therapeutics this year?

The ROCE of Carisma Therapeutics is -3.34 undefined this year.

How has the ROCE (Return on Capital Employed) of Carisma Therapeutics developed compared to the previous year?

The ROCE of Carisma Therapeutics has increased by -3,984.5% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Carisma Therapeutics?

A high Return on Capital Employed (ROCE) indicates that Carisma Therapeutics has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Carisma Therapeutics?

A low ROCE (Return on Capital Employed) can indicate that Carisma Therapeutics has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Carisma Therapeutics impact the company?

An increase in the ROCE of Carisma Therapeutics can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Carisma Therapeutics affect the company?

A decrease in ROCE of Carisma Therapeutics can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Carisma Therapeutics?

Some factors that can affect Carisma Therapeutics's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Carisma Therapeutics so important for investors?

The ROCE of Carisma Therapeutics is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Carisma Therapeutics take to improve the ROCE?

To improve the ROCE, Carisma Therapeutics can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Carisma Therapeutics pay?

Over the past 12 months, Carisma Therapeutics paid a dividend of 0.36 USD . This corresponds to a dividend yield of about 44.71 %. For the coming 12 months, Carisma Therapeutics is expected to pay a dividend of 0.36 USD.

What is the dividend yield of Carisma Therapeutics?

The current dividend yield of Carisma Therapeutics is 44.71 %.

When does Carisma Therapeutics pay dividends?

Carisma Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Carisma Therapeutics?

Carisma Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Carisma Therapeutics?

For the upcoming 12 months, dividends amounting to 0.36 USD are expected. This corresponds to a dividend yield of 42.82 %.

In which sector is Carisma Therapeutics located?

Carisma Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Carisma Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Carisma Therapeutics from 3/8/2023 amounting to 0.361 USD, you needed to have the stock in your portfolio before the ex-date on 3/8/2023.

When did Carisma Therapeutics pay the last dividend?

The last dividend was paid out on 3/8/2023.

What was the dividend of Carisma Therapeutics in the year 2023?

In the year 2023, Carisma Therapeutics distributed 0 USD as dividends.

In which currency does Carisma Therapeutics pay out the dividend?

The dividends of Carisma Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Carisma Therapeutics

Our stock analysis for Carisma Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Carisma Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.